Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by witekon Mar 22, 2011 7:10pm
532 Views
Post# 18324712

Jennings Capital rates QEI speculative buy

Jennings Capital rates QEI speculative buy
Recommendation:  SPECULATIVE BUY 
QUETZAL ENERGY LTD. 12-Month Target:  
.30 
(TSXV-QEI C
.11) Risk Rating:  ABOVE AVERAGE 
FURTHER CLARITY ON CANAGUARO UPSIDE 
Canaguaro Update. We have revised our Canaguaro type 
curve from our previous 2,500 Bbl/d initial production rate, 
declining thereafter to a profile that produces at 2,000 Bbl/d for 
18 months.  
? Our estimated profile is still lower than the operator’s 
production estimate range, with an ESP installed, of 
3,000 Bbl/d to 4,000 Bbl/d.  We consider our estimate 
conservative, given that during a short-period mechanical 
operational test of the ESP at Canaguay-1, the well produced 
oil at rates in excess of 3,900 Bbl/d.
? The long-term production test will likely produce 2,000 Bbl/d 
for its duration (approximately six months); however, the well 
could produce 2,000 Bbl/d far after the long-term production 
test has been completed, given the electric submersible pump 
that was installed has a production capacity of 6,000 Bbl/d 
and given no water has been produced to-date – leaving 
ample capacity to handle the inevitable water production.   
? In addition, one of the partners has indicated that it will likely 
employ reservoir management techniques, which we interpret 
as maintaining a plateau production level for an extended 
period of time – ergo the potential exists to produce at a 
plateau level in excess of 2,000 Bbl/d. 
? Given the ample capacity, and given that no water has been 
produced, we have chosen to model a flat production profile 
of 2,000 Bbl/d for 18 months, with production declining at that 
point as water production materially begins to alter the 
oil/water ratio. 
? Based on a 10-well program, with five wells targeting the 
Canaguay structure and five wells targeting the identified 
structure to the southeast (at a lower chance of success), we 
have included a value of US
.11/share in our ExNAV 
calculation. 
Catalysts. The Canaguay-2 appraisal well should spud mid-
2011 and could be cased and evaluated near the end of Q3/11. 
Around the same time, the long-term production test for 
Canaguay-1 should be completed and the initial rate of full 
production established.   
? The first exploration well on LLA-27 in June 2011, located just 
to the south of the La Punta block, where three wells have 
been drilled on a fault trend that appears to continue into LLA-
27 - the most recent well, was producing 3,377 Bbl/d in one 
month, on natural flow. 
We reiterate our SPECULATIVE BUY recommendation and 
12-month target price of C
.30 per share.  Quetzal has 
ample catalysts in Canaguaro and Block 27 to drive its share 
price up in the short-term.  
Sector: OIL & GAS 
Analyst:  DAVID RICCIARDI, CFA 
e-mail: david.ricciardi@jenningscapital.com 
Tel: (403) 262-0906 Fax: (403) 262-0904 
Associate:  JAMES HUMEN, CA 
e-mail: james.humen@jenningscapital.com 
Tel: (403) 292-9487 Fax: (403) 262-0904 
Quetzal Energy Ltd. is a Canadian-based oil producer with 
operations in Colombia and Guatemala. The Company’s portfolio 
of prospects is weighted toward high-risk exploration, with a recent 
success on its 25% W.I. Canaguaro block. Future development at 
Canaguaro will assist in funding higher risk exploratory prospects. 
https://www.quetzalenergy.com/
Company Statistics
Market Cap $66.1 MM
Basic Shares O/S 600.8 MM
Fully Diluted Shares O/S 893.5 MM
52-Week Range
.10 -
.26
Cash & Cash Equivalents (09/30/10 act.)
Long-term Debt (09/30/10 act.)
Working Capital (09/30/10 act.)
Earnings Summary
FYE: December 2009A 2010F 2011F 2012F
WTI (US$/Bbl) $61.62 $79.50 $95.75 $92.25
Production (Boe/d) 0 0 493 1,637
EPS (US$/FD sh) (
.01) (
.01)
.00
.01
CFPS (US$/FD sh) (
.01) (
.00)
.00
.02
DACF (US$/FD sh) (
.01) (
.00)
.00
.02
Trading Parameters
EV/BOE/d nm nm $118,822 $36,453
P/E nm nm 44.9x 8x
P/CF nm nm 25.6x 5.5x
DACFM nm nm 9.2x 2.0x
-US
.4 MM
US$2.5 MM
US
.0 MM 2 
The information contained in this report was obtained from sources we believe to be reliable.  We do not represent that such information is accurate of 
complete and it should not be relied on as such.  Any opinions expressed herein reflect our judgment at this date and are subject to change.  Jennings 
Capital Inc. and/or employees from time to time may hold shares, options or warrants on any issue included in this report and may buy or sell such 
securities.  This report is not to be construed as an offer to sell or solicitation to buy securities. Member – CIPF.  Jennings Capital (USA) Inc. is a 
member of SIPC. 
Exhibit 1:  Quetzal Target Price 
Method Parameter FX Multiple Valuation Weight
Weighted 
Valuation
(US$/sh) US$/C$ (C$/sh) (C$/sh)
ExNAV
.32 1.00        1.0X
.32 100.0%
.32
Target Price
.30
Current Price
.11
12-month Gain 173%
Exhibit 2:  Quetzal Net Asset Value and Exploration Risked Net Asset Value 
Reserves Mix Unit Value
MMBoe % Gas US$/Boe US$MM US$/share
Oil & Gas Assets 
(1)
Proved Reserves 0.1         -         $23.88 $3.2
.00
Probable Reserves 2.3         -         $27.20 $62.0
.07
Total Proved Plus Probable Reserves 2.4         -         $27.02 $65.2
.07
Net Cash (Debt) $30.2
.03
Proceeds from warrants and options
.0
.00
Net Asset Value (FD)  $95.5
.11
Block Country
Unrisked 
Remaining 
Resources
Working 
Interest 
(3)
Net Unrisked 
Remaining 
Resources
Chance of 
Success
MMBoe % MMBoe US$MM US$/share % US$MM US$/share
Canaguaro Colombia 19.3            25.0% 4.8                  $119.8
.13 90.0% $100.7
.11
LLA-27 Colombia 9.7              34.3% 3.3                  $45.3
.05 35.0% $15.8
.02
LLA-21 
(2)
Colombia 5.7              35.0% 2.0                  $27.2
.03 25.0% $6.8
.01
LLA-36 Colombia 15.5            14.0% 1.9                  $29.6
.03 25.0% $7.4
.01
Total Upside 50.2            12.0                $221.9
.25 $130.8
.15
Proceeds from warrants and options $56.0
.06
Exploration Risked Net Asset Value (FD) $282.2
.32
(1) PV13, after-tax includes the substitution of JCI price forecast.
(2) Estimated, actual resource not disclosed. 
(3) Working interests are post-payout.
Risked NPV
Unrisked NPV Risked NPV 3 
The information contained in this report was obtained from sources we believe to be reliable.  We do not represent that such information is accurate of 
complete and it should not be relied on as such.  Any opinions expressed herein reflect our judgment at this date and are subject to change.  Jennings 
Capital Inc. and/or employees from time to time may hold shares, options or warrants on any issue included in this report and may buy or sell such 
securities.  This report is not to be construed as an offer to sell or solicitation to buy securities. Member – CIPF.  Jennings Capital (USA) Inc. is a 
member of SIPC. 
Exhibit 3:  Quetzal Production, Cash Flow and Earnings Forecast 
2009A 2010F 2011F 2012F
Production (Bbl/d) 0 0 493 1,637
WTI (US$/Bbl) $61.62 $79.50 $95.75 $92.25
Realized Oil Price (US$/Bbl) na na $86.18 $83.03
Net Revenue (US$MM)
.0
.1 $14.3 $45.8
Operating costs (US$MM)
.0
.0 -$2.7 -$9.0
Exploration expense (US$MM)
.0
.0
.0
.0
G&A (US$MM) -$3.0 -$4.0 -$4.2 -$4.4
Interest expense (US$MM) -
.1 -
.1
.0
.0
DD&A (US$MM)
.0
.0 -$2.7 -$9.0
Stock compensation (US$MM) -
.2 -
.8
.0
.0
F/X & Other (US$MM)
.2
.0
.0
.0
-$3.1 -$4.9 -$9.5 -$22.4
Earnings before taxes (US$MM) -$3.0 -$4.8 $4.8 $23.4
Current (US$MM)
.0
.0 -$1.2 -$3.5
Future (US$MM) -
.8 -
.2
.0
.0
Income taxes (US$MM) -
.8 -
.2 -$1.2 -$3.5
Earnings (US$MM) -$3.8 -$5.0 $3.6 $19.9
(US$/sh, FD) -
.01 (
.01)
.00
.01
Cash flow (US$MM) -$2.8 -$2.7 $6.3 $28.9
(US$/sh, FD) -
.01 (
.00)
.00
.02
DACF (US$MM) -$2.7 -$2.6 $6.3 $28.9
(US$/sh, FD) -
.01 (
.00)
.00
.02
Capital expenditures (US$MM) $2.4 $16.3 $35.0 $30.0
YE Debt  (US$MM)
.0
.0
.0
.04 
Jennings Capital Inc. Research Disclosures 
Company Ticker 
Quetzal Energy Ltd. TSXV-QEI 
I, David Ricciardi, hereby certify that the views expressed in this report accurately reflect my personal views about the subject securities or issuers. I 
also certify that I have not, am not, and will not receive, directly or indirectly, compensation in exchange for expressing the specific recommendations or 
views in this report. 
Note: We initiated coverage on Quetzal Energy Ltd. on December 13, 2010 with a SPECULATIVE BUY recommendation, an ABOVE AVERAGE risk 
rating and a C
.40 target price.  Share price at that time was C
.185.  On February 7, 2011, we reduced our target price to C
.30.  Share price at 
that time was C
.135. 
Bullboard Posts